Indications, Timing, and Outcome of Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction: A

Modar Alhamdan1, Alba Corell2, Klas Holmgren3

  • 1Department of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.

World Neurosurgery
|December 28, 2025
PubMed
Abstract

Insights

Decompressive hemicraniectomy (DC) for malignant middle cerebral artery infarction (MMI) shows varied real-world application compared to clinical trials. Despite differing indications and timing, outcomes were consistent across Swedish centers.

Area of Science:

  • Neurosurgery
  • Neurology
  • Critical Care Medicine

Background:

  • Malignant middle cerebral artery infarction (MMI) presents a high mortality risk due to severe edema.
  • Decompressive hemicraniectomy (DC) is a proven intervention in randomized controlled trials (RCTs) for selected MMI patients.
  • Real-world data on DC for MMI is less comprehensively documented.

Purpose of the Study:

  • To evaluate the indications, timing, and outcomes of DC in MMI patients across four Swedish neurosurgical centers.
  • To assess the alignment of real-world patient selection for DC with criteria from landmark RCTs (DESTINY I & II).

Main Methods:

  • A retrospective multi-center cohort study involving 335 MMI patients treated with DC (2008-2022).
  • Data collected included demographics, clinical/radiological status, surgical factors, and 6-month outcomes (modified Rankin Scale [mRS]).
  • Comparisons were made across centers and against DESTINY trial eligibility criteria.

Main Results:

  • The study included 335 MMI patients; 75% were male, with a median age of 55.
  • DC was performed at a median of 38 hours post-stroke onset.
  • Median 6-month mRS was 4, with 24% achieving mRS ≤3 and a 17% mortality rate. Critically, only 19% and 12% met DESTINY I and II criteria, respectively.

Conclusions:

  • Significant variations exist in DC indications and timing for MMI treatment across centers and compared to RCTs.
  • Despite these practice variations, functional outcomes and mortality rates were comparable across the participating centers.
  • This study offers valuable insights into the outcomes of DC for MMI when applied outside strict RCT eligibility criteria.

Related Concept Videos